These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35189315)

  • 1. Programmable and monitorable intradermal vaccine delivery using ultrasound perforation array.
    Hu Y; Mo Y; Wei J; Yang M; Zhang X; Chen X
    Int J Pharm; 2022 Apr; 617():121595. PubMed ID: 35189315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin immunization with third-generation hepatitis B surface antigen using microneedles.
    Nguyen TT; Choi JA; Kim JS; Park H; Yang E; Lee WJ; Baek SK; Song M; Park JH
    Vaccine; 2019 Sep; 37(40):5954-5961. PubMed ID: 31466705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.
    Scheiblhofer S; Strobl A; Hoepflinger V; Thalhamer T; Steiner M; Thalhamer J; Weiss R
    Vaccine; 2017 Mar; 35(14):1802-1809. PubMed ID: 28117172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minipigs as an animal model for dermal vaccine delivery.
    Ploemen IH; Hirschberg HJ; Kraan H; Zeltner A; van Kuijk S; Lankveld DP; Royals M; Kersten GF; Amorij JP
    Comp Med; 2014 Feb; 64(1):50-4. PubMed ID: 24512961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.
    Fabrizi F; Andrulli S; Bacchini G; Corti M; Locatelli F
    Nephrol Dial Transplant; 1997 Jun; 12(6):1204-11. PubMed ID: 9198052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) and intradermal hepatitis B vaccination.
    Nagafuchi S; Kashiwagi S; Hayashi J; Katsuta H; Ikematsu H; Harada M
    Fukuoka Igaku Zasshi; 2004 Dec; 95(12):305-13. PubMed ID: 15732372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micro-fractional epidermal powder delivery for improved skin vaccination.
    Chen X; Kositratna G; Zhou C; Manstein D; Wu MX
    J Control Release; 2014 Oct; 192():310-6. PubMed ID: 25135790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.
    Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ
    PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells.
    Chou HY; Lin XZ; Pan WY; Wu PY; Chang CM; Lin TY; Shen HH; Tao MH
    J Immunol; 2010 Nov; 185(9):5468-75. PubMed ID: 20889541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice.
    Grenfell RF; Shollenberger LM; Samli EF; Harn DA
    Clin Vaccine Immunol; 2015 Mar; 22(3):336-43. PubMed ID: 25609075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous vaccination: antigen delivery into or onto the skin.
    Weniger BG; Glenn GM
    Vaccine; 2013 Jul; 31(34):3389-91. PubMed ID: 23684830
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12.
    Schirmbeck R; Reimann J
    Intervirology; 2001; 44(2-3):115-23. PubMed ID: 11509872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
    Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
    J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID™.
    Van Mulder TJS; Withanage K; Beyers KCL; Vankerckhoven VVJ; Theeten H; Van Damme P
    Vaccine; 2019 Jan; 37(4):581-586. PubMed ID: 30587432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
    Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
    Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
    Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
    Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays.
    Guo L; Qiu Y; Chen J; Zhang S; Xu B; Gao Y
    Biomed Microdevices; 2013 Dec; 15(6):1077-85. PubMed ID: 23893014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.